I-MOVIX and Polecam Deliver A New Way to Use Ultra Slow Motion
posted:
Featuring an I-MOVIX X10 Spine with the compact Vision Research Phantom Miro 320S high-speed camera, the system operates at frame rates up to 1,500 FPS in 1920x1080 resolution (and up to 3,000 FPS in 1280x720) with instant replay, and offers the major operational advances provided by the X10 technology, while the Miro 320S camera itself can be used for additional non-broadcast shooting.
“As shown by Logo2 Producciones in its advanced productions under the direction of Victor Santamaria, for matches like El Clássico between Real Madrid and FC Barcelona, I-MOVIX ultra slow motion combined with the freedom of movement of Polecam cranes delivers an unbeatable sense of intimacy and insight into the action,” said Steffan Hewitt, Director Polecam Ltd.
advertisment
“Using I-MOVIX X10 Spine with Polecam cranes offers production teams a superb complement to our fixed camera and RF solutions,” said Laurent Renard, CEO of I-MOVIX. “It’s another extension of creativity for directors and camera operators, and one more step towards making ultra slow motion a ubiquitous tool in sports coverage.”
About Polecam
Polecam Limited is active globally from its Headquarters base near Bedford, England and is recognised across many different markets to include Broadcast, Extreme Sports, Medical, Military & Security, Industrial & Commercial, Corporate, Natural History and emerging markets for specialist Property, Wedding and Music environments; as the market leader for super lightweight, highly portable camera jib, minicams, lenses and remote control systems.
advertisment
About I-MOVIX
I-MOVIX is the worldwide leader in extreme slow motion for sports broadcast (from 75 to over 5,000 FPS). The company’s products are the first true ultra-slow motion systems, fully integrated for broadcast use, offering the unprecedented combination of very high frame rates and instant replay, or continuous streaming. The technology has applications in live sports and other live TV productions, as well as in commercials, documentaries, feature films, and scientific R&D.